Skip to main content
profile image
Selected Works of Samuel Neuhut, MD, FAPA
Article
Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
Cureus (2020)
  • Ian H Rutkofsky, Psychiatry, Aventura Hospital and Medical Center, Aventura, USA.
  • Kristy A Fisher, Psychiatry, Aventura Hospital and Medical Center, Aventura, USA.
  • Clara L Alvarez Villalba, Psychiatry, Aventura Hospital and Medical Center, Aventura, USA.
  • Samuel Neuhut, Psychiatry, Aventura Hospital and Medical Center, Aventura, USA.
Link
Disciplines
Publication Date
June 30, 2020
DOI
10.7759/CUREUS.8931
Citation Information
Ian H Rutkofsky, Kristy A Fisher, Clara L Alvarez Villalba and Samuel Neuhut. "Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review" Cureus Vol. 12 Iss. 6 (2020)
Available at: http://works.bepress.com/samuel-neuhut/2/